Savara Biotech Nears Pivotal Moment with Promising Lung Disease Treatment
Savara Biotech, a small-cap biopharmaceutical company, is approaching a critical juncture in its development of an innovative therapy for a...
My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers.
My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world.
A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses.
In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.
Savara Biotech, a small-cap biopharmaceutical company, is approaching a critical juncture in its development of an innovative therapy for a...
In a bold move that sent shockwaves through Wall Street, Warren Buffett's Berkshire Hathaway has acquired a $1.6 billion stake...
Chevron shareholders are marking their calendars as the energy giant's quarterly dividend deadline arrives today. Investors holding shares as of...
The energy sector witnessed a dramatic selloff in Northern Oil & Gas (NOG) shares this week following a double blow...
While C3.ai secures a significant partnership with Brazil's Eletrobras to deploy its AI-powered grid management technology, the enterprise software company...
BioNTech has achieved another significant regulatory milestone as Health Canada grants authorization for the biotech firm's latest COVID-19 vaccine formulation....
A major creditor has challenged the court-approved sale of Sunnova Energy, throwing the solar provider's Chapter 11 restructuring into uncertainty....
The tide may be turning for nCino’s cloud-based banking software as heavyweight institutional investors significantly increase their stakes. Despite the...
Pharmaceutical giant Eli Lilly is facing its worst stock market performance in 25 years, with shares plummeting 14% in a...
Shares of semiconductor design leader Synopsys continue demonstrating resilience, yet recent activity reveals intriguing contrasts: Senior executives have offloaded millions...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.